ES2076363T3 - Preparacion de agentes terapeuticos de fosfonato de renio. - Google Patents

Preparacion de agentes terapeuticos de fosfonato de renio.

Info

Publication number
ES2076363T3
ES2076363T3 ES90905853T ES90905853T ES2076363T3 ES 2076363 T3 ES2076363 T3 ES 2076363T3 ES 90905853 T ES90905853 T ES 90905853T ES 90905853 T ES90905853 T ES 90905853T ES 2076363 T3 ES2076363 T3 ES 2076363T3
Authority
ES
Spain
Prior art keywords
solution
renium
phosphonate
preparation
therapeutic agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90905853T
Other languages
English (en)
Inventor
David W Pipes
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mallinckrodt Inc
Original Assignee
Mallinckrodt Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mallinckrodt Inc filed Critical Mallinckrodt Inc
Application granted granted Critical
Publication of ES2076363T3 publication Critical patent/ES2076363T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0474—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
    • A61K51/0478—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group complexes from non-cyclic ligands, e.g. EDTA, MAG3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0489—Phosphates or phosphonates, e.g. bone-seeking phosphonates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Optics & Photonics (AREA)
  • Epidemiology (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Electrical Control Of Ignition Timing (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

EL PROCESO DE ESTA INVENCION INCLUYE EL PREPARAR UNA PRIMERA SOLUCION ACUOSA DE RENIO EN FORMA DE UN PERIENATO RADIACTIVO, DONDE LA CONCENTRACION DE RENIO EN DICHA SOLUCION ESTA DENTRO DE UN PROMEDIO DE ALREDEDOR DE 5 X 10 ELEVADO 6 M A ALREDEDOR DE 2 X 10 ELEVADO -3 M, Y DESPUES REDUCIR Y COMPLEJAR EL PERRENATO RADIACTIVO AL MEZCLAR UNA SEGUNDA SOLUCION O SOLIDO LIOFILIZADO CON LA PRIMERA SOLUCION. LA SEGUNDA SOLUCION O SOLIDO LIOFILIZADO COMPRENDE UN LIGANDO QUE SE COMPLEJA CON EL PERRENATO RADIACTIVO Y UN REDUCTANTE DONDE EL REDUCTANTE ESTA PRESENTE EN LA SEGUNDA SOLUCION EN UNA CONCENTRACION EN UN PROMEDIO DE ALREDEDOR DE 0,005 M A 0,020 M APROXIMADAMENTE, Y EL LIGANDO ESTA PRESENTE EN LA SEGUNDA SOLUCION EN UNA CONCENTRACION EN UN PROMEDIO DE ALREDEDOR DE 0,01 M A 0,15 M APROXIMADAMENTE. EL PH DE LA SOLUCION RESULTANTE ESTA DENTRO DEL PROMEDIO DE 1,5 A 5,5 APROXIMADAMENTE.
ES90905853T 1989-05-02 1990-03-12 Preparacion de agentes terapeuticos de fosfonato de renio. Expired - Lifetime ES2076363T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/346,411 US5021235A (en) 1989-05-02 1989-05-02 Preparation of rhenium phosphonate therapeutic agents for bone cancer without purification

Publications (1)

Publication Number Publication Date
ES2076363T3 true ES2076363T3 (es) 1995-11-01

Family

ID=23359259

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90905853T Expired - Lifetime ES2076363T3 (es) 1989-05-02 1990-03-12 Preparacion de agentes terapeuticos de fosfonato de renio.

Country Status (10)

Country Link
US (1) US5021235A (es)
EP (1) EP0470965B1 (es)
JP (1) JP3080984B2 (es)
AT (1) ATE124268T1 (es)
AU (1) AU646801B2 (es)
CA (1) CA2064063A1 (es)
DE (1) DE69020556T2 (es)
DK (1) DK0470965T3 (es)
ES (1) ES2076363T3 (es)
WO (1) WO1990013530A1 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5393512A (en) * 1985-01-14 1995-02-28 Vanderheyden; Jean-Luc Stable therapeutic radionuclide compositions and methods for preparation thereof
US5985240A (en) * 1989-08-09 1999-11-16 Rhomed Incorporated Peptide radiopharmaceutical applications
US5320824A (en) * 1989-10-12 1994-06-14 Mallinckrodt Medical, Inc. Radionuclide labelled particles useful for radiation synovectomy
JP3370666B2 (ja) * 1990-07-06 2003-01-27 マリンクロッド・インコーポレイテッド 放射性レニウム錯体溶液の調製法
US5186913A (en) * 1991-04-26 1993-02-16 Martin Marietta Energy Systems, Inc. Tungsten-188/carrier-free rhenium-188 perrhenic acid generator system
US6106473A (en) * 1996-11-06 2000-08-22 Sts Biopolymers, Inc. Echogenic coatings
RU2164420C2 (ru) * 1999-02-10 2001-03-27 Государственный научный центр Российской Федерации Физико-энергетический институт им. акад. А.И. Лейпунского Способ получения радиотерапевтического препарата
KR20020023636A (ko) * 2000-09-23 2002-03-29 송영욱 신규한 방사성 레늄 주석 화합물
RU2432965C1 (ru) * 2010-05-12 2011-11-10 Учреждение Российской академии медицинских наук Медицинский радиологический научный центр РАМН (МРНЦ РАМН) Способ получения радиофармпрепарата для радионуклидной терапии

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3192011A (en) * 1963-08-07 1965-06-29 Chase Brass & Copper Co Process for producing high purity rhenium compounds
US3983227A (en) * 1973-05-23 1976-09-28 The Procter & Gamble Company Dry mixture containing diphosphonates and a stannous salt useful in the preparation of Tc99M containing bone scanning agents
US4652440A (en) * 1984-05-03 1987-03-24 Paik Chang H Method of stably radiolabeling antibodies with technetium and rhenium
US4778672A (en) * 1985-11-27 1988-10-18 University Of Cincinnati Method of isolating radioactive perrhenate or pertechnetate from an aqueous solution
US4935222A (en) * 1986-06-13 1990-06-19 University Of Cincinnati Procedure for isolating and purifying radioactive ligated rhenium pharmaceuticals and use thereof and kit
EP0300431A3 (en) * 1987-07-22 1990-06-27 Neorx Corporation Method of radiolabeling chelating compounds comprising sulfur atoms with metal radionuclides
US4925925A (en) * 1988-06-15 1990-05-15 University Of Cincinnati Radioactive rhenium ligated to 2-hydroxy isobutyric acid and method of use

Also Published As

Publication number Publication date
US5021235A (en) 1991-06-04
JP3080984B2 (ja) 2000-08-28
JPH05500042A (ja) 1993-01-14
AU646801B2 (en) 1994-03-10
DE69020556D1 (de) 1995-08-03
DE69020556T2 (de) 1995-11-02
DK0470965T3 (da) 1995-08-28
EP0470965A1 (en) 1992-02-19
WO1990013530A1 (en) 1990-11-15
CA2064063A1 (en) 1990-11-03
ATE124268T1 (de) 1995-07-15
AU5355490A (en) 1990-11-29
EP0470965B1 (en) 1995-06-28

Similar Documents

Publication Publication Date Title
ZA878952B (en) Metal complex-containing pharmaceutical agents
DE3485649D1 (de) Verfahren zur herstellung von antikoerperzusammensetzungen von therapeutischen mitteln mit verlaengerter serumhalbwertzeit.
FI982303L (fi) Menetelmä terapeuttisesti aktiivisten, makrosyklisten bifunktionaalisten kelaatinmuodostajien komplekseja sisältävien vasta-ainekonjugaattien valmistamiseksi
GR3018074T3 (en) Treatment of fabric with perfume/cyclodextrin complexes.
IL89175A (en) Ultrasonic contrast agents and processes for the preparation thereof
EP0175315A3 (en) 4-dimethylamino-1-hydroxybutane-1,1-diphosphonic acid, its water soluble salts, process for their preparation and its use
DE59006490D1 (de) Chelatbildner zur Komplexierung von radioaktiven Isotopen, deren Metallkomplexe sowie ihre Verwendung in Diagnostik und Therapie.
ES2065906T3 (es) Produccion de proteinas en formas activas.
ES2076363T3 (es) Preparacion de agentes terapeuticos de fosfonato de renio.
ATE98631T1 (de) Verfahren zur herstellung von komplexverbindungen.
TR24861A (tr) Celikten hazirlanan parcalarin nitrokarbonlanmasi icin bir islem
HUT44267A (en) Process for preparing new organic platinum complexes
DE68921582D1 (de) Verfahren zur Herstellung von funktionellen Isothiocyanatometallkomplexen.
GB2019405A (en) Pt (II) and (IV) Amino-Acid Complexes
DE3671452D1 (de) Technetium-aren-komplexe und verfahren.
KR950700765A (ko) 활성 시약 착화합물의 제조방법(Process for producing active agent complexes)
FI904892A7 (fi) Menetelmä vesipitoisten sekamiselliliuosten valmistamiseksi
ATE137487T1 (de) Komplexe, enthaltend s(+)-phenyl-alkansäuren und alpha-hydroxy-alkansäuren
DE69117741D1 (de) Neue vorangeordnete sechszähnige liganden verwendbar in röntgenologischen bildformenden wirkstoffen
KR920002488A (ko) 바이오 세라믹을 처리하는 페드(Pad) 및 부직포의 제조방법
DK0489771T3 (da) Modificerede humane anti-Rh(D)-antistoffer
IL98750A0 (en) Preparation of a radioactive rhenium complex
DE69019789D1 (de) Zusammensetzung für die Diagnose und Behandlung insbesondere von Krebs.
NO954045D0 (no) Fremgangsmåte ved fremstilling av antistoffkonjugater med makrocykliske biofunkjonelle chelaterte komplekser

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 470965

Country of ref document: ES